Cerebrospinal fluid exposure of cenicriviroc in HIV-positive individuals with cognitive impairment

被引：0
|
作者：
Alagaratnam, J. [1 ]
Else, L. [2 ]
Penchala, S. Dilly [2 ]
Challenger, E. [2 ]
Legg, K. [1 ]
Petersen, C. [3 ]
Jones, B. [4 ]
Kulasegaram, R. [5 ]
Seyedkazemi, S. [6 ]
Lefebvre, E. [7 ]
Khoo, S. [2 ]
Winston, A. [1 ]
机构：
[1] Imperial Coll London, Dept Infect Dis, London, England
[2] Univ Liverpool, Dept Pharmacol, Liverpool, Merseyside, England
[3] Imperial Coll London, Clin Trials Ctr, London, England
[4] Imperial Coll Healthcare NHS Trust, Dept Radiol, London, England
[5] St Thomas Hosp, Dept GU HIV, London, England
[6] Allergan Plc, Clin Dev, San Francisco, CA USA
[7] Allergan Plc, R&D, San Francisco, CA USA
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2018年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P022
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Acute HCV in HIV-positive individuals - A review
    Danta, M.
    Dusheiko, G. M.
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (17) : 1690 - 1697
  • [42] Reaction Time Variability in HIV-Positive Individuals
    Ettenhofer, Mark L.
    Foley, Jessica
    Behdin, Nina
    Levine, Andrew J.
    Castellon, Steven A.
    Hinkin, Charles H.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2010, 25 (08) : 791 - 798
  • [43] Lymphoid neoplasms in HIV-positive individuals in India
    Agarwal, B
    Ramanathan, U
    Lokeshwas, N
    Nair, R
    Gopal, R
    Bhatia, K
    Naresh, KN
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (02) : 181 - 183
  • [44] Epidemiology and prevalence of onychomycosis in HIV-positive individuals
    Gupta, AK
    Taborda, P
    Taborda, V
    Gilmour, J
    Rachlis, A
    Salit, I
    Gupta, MA
    MacDonald, P
    Cooper, EA
    Summerbell, RC
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2000, 39 (10) : 746 - 753
  • [45] Malassezia yeast density in HIV-positive individuals
    Pechere, M
    Saurat, JH
    BRITISH JOURNAL OF DERMATOLOGY, 1997, 136 (01) : 138 - 139
  • [46] Apathy correlates with cognitive performance, functional disability, and HIV RNA plasma levels in HIV-positive individuals
    Shapiro, Miriam E.
    Mahoney, Jeannette R.
    Zingman, Barry S.
    Pogge, David L.
    Verghese, Joe
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2013, 35 (09) : 934 - 945
  • [47] Clinical, cerebrospinal fluid and pathological findings and outcomes in HIV-positive and HIV-negative patients with tuberculous meningitis
    Schutte, CM
    INFECTION, 2001, 29 (04) : 213 - 217
  • [48] Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment
    Rozek, Wojciech
    Ricardo-Dukelow, Mary
    Holloway, Sondra
    Gendelman, Howard E.
    Wojna, Valerie
    Melendez, Loyda. M.
    Ciborowski, Pawel
    JOURNAL OF PROTEOME RESEARCH, 2007, 6 (11) : 4189 - 4199
  • [49] Clincal, Cerebrospinal Fluid and Pathological Findings and Outcomes in HIV-Positive and HIV-Negative Patients with Tuberculous Meningitis
    C.-M. Schutte
    Infection, 2001, 29 : 213 - 217
  • [50] Cerebrospinal fluid abacavir concentrations in HIV-positive patients following once-daily administration
    Calcagno, A.
    Pinnetti, C.
    De Nicolo, A.
    Scarvaglieri, E.
    Gisslen, M.
    Tempestilli, M.
    D'Avolio, A.
    Fedele, V
    Di Perri, G.
    Antinori, A.
    Bonora, S.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (06) : 1380 - 1383
12345